Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors

US Patent 11034661 · Granted Jun 15, 2021

Estimated economic value: $253,758,000

Assignee

Inventors

View full patent text on Google Patents →